Novo Nordisk's stock slumps after study finds Wegovy lags Lilly's Mounjaro in speed and scale of weight lossMarket Watch • 07/09/24
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight lossReuters • 07/09/24
Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's OzempicInvestors Business Daily • 07/08/24
Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sectorReuters • 07/05/24
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye conditionCNBC • 07/04/24
Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To BlindnessInvestors Business Daily • 07/03/24
Surprise! Novo Nordisk's Wegovy Just Achieved Another Milestone. Here's What You Need to Know.The Motley Fool • 06/30/24
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment lossGlobeNewsWire • 06/26/24